Skip to main content
. 2020 Sep 12;47(2):465–473. doi: 10.1093/schbul/sbaa130

Table 2.

Cumulative predicted costs during the 3-year trial, by type of cost and by experimental group, in 2018 Canadian dollars

Control group Intervention group Adjusted differencea
Costs Mean (95% CI) Mean (95% CI) Coefficient (95% CI)
Mental health costs
 Hospitalizations 13 348 (7516 to 19 180) 12 342 (6628 to 18 056) −1006 (−9172 to 7160)
 Medications 5432 (4373 to 6491) 6712 (5674 to 7750) 1280 (−203 to 2763)
 Physician services 4468 (3227 to 5709) 4294 (3077 to 5510) −174 (−1912 to 1564)
 Total mental health costs 27 222 (19 285 to 35 158) 31 233 (23 457 to 39 009) 4011 (−7101 to 15 123)
Somatic health costs
 Hospitalizations 128 (20 to 236) 71 (−35 to 177) −58 (−209 to 94)
 Medications 302 (163 to 441) 199 (63 to 335) −103 (−298 to 92)
 Physician services 528 (145 to 911) 847 (472 to 1222) 319 (−217 to 856)
 Total somatic health costs 979 (522 to 1437) 1097 (649 to 1545) 118 (−523 to 758)
Nonphysician visits 3777 (2248 to 5307) 8073 (6575 to 9572) 4296 (2155 to 6437)
Total costs 28 199 (20 089 to 36 309) 32 332 (24 386 to 40 278) 4133 (−7222 to 15 488)

aEstimated difference adjusting for differences at baseline.